Legal Representation
Attorney
Greg Lam
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 17, 2018 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 17, 2018 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Mar 25, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 25, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 25, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 17, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 15, 2017 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 14, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 8, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing an interactive computer database of researchers and consultants in the field of research, drug development, and education focused on diseases of the central nervous system and providing information and education on the subject of scientific research in the field of diseases of the central nervous system
First Use Anywhere:
Aug 12, 2014
First Use in Commerce:
Aug 12, 2014
Additional Information
Design Mark
The mark consists of an isosceles triangle with an open right side through which there is a straight line leading to the acronym "ADDF" in all capital letters above the word "ACCESS" in all capital letters.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ALZHEIMER'S DRUG DISCOVERY FOUNDATION ACCESS
Classification
International Classes
042